As of December 31, 2020, Athanase Innovation AB has 3.00M shares outstanding.
| Shares Outstanding | 3.00M |
As of December 31, 2020, Athanase Innovation AB maintains a current ratio of 58.23, meaning it holds 58.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 58.23 |
| Quick Ratio | 58.22 |
As of the close on October 15, 2026, Athanase Innovation AB's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 16.03, while the 200-day moving average is 18.97.
| 50-Day Moving Average | 16.03 |
| 200-Day Moving Average | 18.97 |
These figures are as of December 31, 2020. Total book value stands at 396.75M, with working capital of 396.75M providing operational flexibility.
| Cash & Cash Equivalents | 403.62M |
| Net Debt | -403.62M |
| Equity (Book Value) | 396.75M |
| Book Value Per Share | 132.25 |
| Working Capital | 396.75M |
Athanase Innovation AB's most recent stock split took place on June 10, 2022 with a 16:1 split ratio.
| Last Split Date | 6/10/2022 |
| Split Ratio | 16:1 |
Already premium?